Prostate Cancer - Results from #25880

Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapy - Abstract May 18, 2012

Safety and tolerability of intermittent androgen deprivation therapy: A literature review - Abstract May 17, 2012

Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): Study protocol for a phase III, multicenter, randomized, controlled trial - Abstract May 17, 2012

Pathologic prostate cancer characteristics in patients eligible for active surveillance: A head-to-head comparison of contemporary protocols - Abstract May 17, 2012

Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years - Abstract May 17, 2012

Postoperative radiotherapy for prostate cancer: A comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT - Abstract May 17, 2012

Pretreatment endorectal coil magnetic resonance imaging findings predict biochemical tumor control in prostate cancer patients treated with combination brachytherapy and external-beam radiotherapy May 17, 2012

Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer - Abstract May 16, 2012

Association between KLK3 rs2735839 G/A polymorphism and serum PSA Levels in Japanese men - Abstract May 16, 2012

Risk of subsequent primary cancer among prostate cancer patients in Bavaria, Germany - Abstract May 16, 2012

Abiraterone acetate: A novel therapeutic option in hormone-refractory prostate cancer - Abstract May 16, 2012

What management for the asymptomatic men carriers of BRCA1 or 2 mutation? Results of a survey in the French oncogenetic centers - Abstract May 16, 2012

Current status of salvage robot-assisted laparoscopic prostatectomy for radiorecurrent prostate cancer - Abstract May 16, 2012

Comparison of health-related quality-of-life outcomes for African-American and Caucasian-American men after radical prostatectomy - Abstract May 16, 2012

Technical refinement and learning curve for attenuating neurapraxia during robotic-assisted radical prostatectomy to improve sexual function - Abstract May 16, 2012

Optimizing the care of patients with advanced prostate cancer in the UK: Current challenges and future opportunities - Abstract May 16, 2012

Lower testosterone levels with luteinizing hormone-releasing hormone agonist therapy than with surgical castration: New insights attained by mass spectrometry - Abstract May 15, 2012

A critical assessment of post-prostatectomy prostate specific antigen doubling time acceleration-is it stable? - Abstract May 15, 2012

Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance - Abstract May 15, 2012

Radical prostatectomy outcome in men 65 years old or older with low risk prostate cancer - Abstract May 15, 2012

Page 1295 of 1437